StockWatch
·

Bharat Parenterals Ltd Q3 FY25 Results

BPLPHARMAQ3 FY25 Results
Filing
MetricValue ( Cr)vs Q2 FY25
Revenue72.260.9%
Total Income75.210.8%
Expenditure80.7111.5%
PBT-5.5064.2%
Net Profit-7.8755.1%
OPM-28.43%15.56pp
NPM-10.46%12.64pp
EPS-10.0063.0%
View full financials

Informational and educational content only. Not investment advice.